Skip to Main Content

Paper Details

Machine Learning to Predict Response to Ranibizumab in Neovascular Age-Related Macular Degeneration.
Ophthalmol Sci
1
2023
Neovascular Age-Related Macular Degeneration, Neovascular age-related macular degeneration, Ranibizumab, age-related macular dengeration, anti-VEGF, nAMD, patients, ranibizumab, subfoveal choroidal neovascularization
Author NameAffiliation
Andreas MaunzRoche Pharma Research and Early Development
Laura Barras
Michael G Kawczynski
Jian Dai
Aaron LeeUniversity of Washington
Richard F Spaide
Jayashree SahniRoche Pharma Research and Early Development
Daniela Ferrara
  • 1 - 8

Datasets

Release 1.2